Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature.
Market Analysis and Insights: Global Immunostimulatory Adjuvants Market
Due to the COVID-19 pandemic, the global Immunostimulatory Adjuvants market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Aluminum Hydroxide Adjuvant accounting for % of the Immunostimulatory Adjuvants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Immunostimulatory Adjuvants market size is valued at US$ million in 2021, while the US and Europe Immunostimulatory Adjuvants are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Immunostimulatory Adjuvants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Immunostimulatory Adjuvants include Bayer, Adjuvance Technologies, Vical, Allergy Therapeutics and BioCentury, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Immunostimulatory Adjuvants Scope and Segment
Immunostimulatory Adjuvants market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Immunostimulatory Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Aluminum Hydroxide Adjuvant
Alum Adjuvant
Liposomes
Others
Segment by Application
Hospitals
Medical Centers
Others
By Company
Bayer
Adjuvance Technologies
Vical
Allergy Therapeutics
BioCentury
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E